PremiumCompany AnnouncementsAstraZeneca Extends COPD Bet With New Long‑Term Tozorakimab Safety Study5h agoAZN
PremiumCompany AnnouncementsAstraZeneca Advances First-in-Human AZD8359 Study in Metastatic Prostate Cancer5h agoAZN